NCT06167902View on ClinicalTrials.gov

The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial

NANot yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

December 25, 2023

Primary Completion Date

December 25, 2024

Study Completion Date

December 25, 2025

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

OTHER

Ginseng oligopeptide (Ginseng extract）

The experimental group was given ginseng oligopeptide preparation 1.2g per day orally.

OTHER

Maltodextrin

The control group was treated with placebo maltodextrin 1.2g/d

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER

NCT06167902 - The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind Trial | Biotech Hunter | Biotech Hunter